down arrow

Ambalal Sarabhai

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE432A01017
  • NSEID: AMBASARABH
  • BSEID: 500009
INR
38.55
1.9 (5.18%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 52.49 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

38.0041.99

52 Week

34.1177.70
Valuation
Technical
Day's Volume

CASH

52.49 k (-48.33%) Volume

Shareholding (Dec 2024)

FII

0.00%

Held by 0 FIIs

DII

0.10%

Held by 2 DIIs

Promoter

31.35%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Poor Management Efficiency with a low ROCE of 4.35%

  • The company has been able to generate a Return on Capital Employed (avg) of 4.35% signifying low profitability per unit of total capital (equity and debt)
2

Flat results in Dec 24

3

Stock is technically in a Bearish range

4

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 295 Cr (Micro Cap)

stock-summary
P/E

20.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.18

stock-summary
Return on Equity

9.49%

stock-summary
Price to Book

2.00

Revenue and Profits (1 Year):
Net Sales:
46 Cr
(Quarterly Results - Dec 2024)
Net Profit:
2 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-36.19%
0%
-36.19%
1 Year
-23.75%
0%
-23.75%
2 Years
70.58%
0%
70.58%
3 Years
3.91%
0%
3.91%
4 Years
101.83%
0%
101.83%
5 Years
108.38%
0%
108.38%

Ambalal Sarabhai for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
5.86%
EBIT Growth (5y)
30.61%
EBIT to Interest (avg)
2.54
Debt to EBITDA (avg)
1.67
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.29
Tax Ratio
6.33%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.10%
ROCE (avg)
3.12%
ROE (avg)
26.07%
Valuation key factors
Factor
Value
P/E Ratio
20
Industry P/E
33
Price to Book Value
2.00
EV to EBIT
59.25
EV to EBITDA
36.47
EV to Capital Employed
1.85
EV to Sales
1.65
PEG Ratio
0.05
Dividend Yield
NA
ROCE (Latest)
4.97%
ROE (Latest)
9.49%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Sarabhai Holdings Private Limited (25.76%)

Highest Public shareholder

Haryana Containers Limited (1.61%)

Individual Investors Holdings

57.08%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 2.84% vs 9.83% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -14.89% vs 648.57% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "45.97",
          "val2": "44.70",
          "chgp": "2.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.70",
          "val2": "2.53",
          "chgp": "-127.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.14",
          "val2": "1.22",
          "chgp": "-6.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2.23",
          "val2": "2.62",
          "chgp": "-14.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1.52%",
          "val2": "5.66%",
          "chgp": "-7.18%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 12.21% vs -15.88% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 178.36% vs -245.77% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "85.40",
          "val2": "76.11",
          "chgp": "12.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.37",
          "val2": "-1.94",
          "chgp": "273.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.17",
          "val2": "1.87",
          "chgp": "16.04%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2.97",
          "val2": "-3.79",
          "chgp": "178.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "3.95%",
          "val2": "-2.55%",
          "chgp": "6.50%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 10.19% vs -5.26% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 311.38% vs -143.85% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "131.37",
          "val2": "119.22",
          "chgp": "10.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2.67",
          "val2": "0.58",
          "chgp": "360.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.31",
          "val2": "2.86",
          "chgp": "15.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "5.20",
          "val2": "-2.46",
          "chgp": "311.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "2.03%",
          "val2": "0.49%",
          "chgp": "1.54%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 1.93% vs -13.45% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -50.39% vs -75.75% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "173.57",
          "val2": "170.28",
          "chgp": "1.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "6.31",
          "val2": "8.57",
          "chgp": "-26.37%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3.76",
          "val2": "2.44",
          "chgp": "54.10%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "5.68",
          "val2": "11.45",
          "chgp": "-50.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "3.64%",
          "val2": "5.03%",
          "chgp": "-1.39%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
45.97
44.70
2.84%
Operating Profit (PBDIT) excl Other Income
-0.70
2.53
-127.67%
Interest
1.14
1.22
-6.56%
Exceptional Items
0.00
0.00
Consolidate Net Profit
2.23
2.62
-14.89%
Operating Profit Margin (Excl OI)
-1.52%
5.66%
-7.18%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 2.84% vs 9.83% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is -14.89% vs 648.57% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
85.40
76.11
12.21%
Operating Profit (PBDIT) excl Other Income
3.37
-1.94
273.71%
Interest
2.17
1.87
16.04%
Exceptional Items
0.00
0.00
Consolidate Net Profit
2.97
-3.79
178.36%
Operating Profit Margin (Excl OI)
3.95%
-2.55%
6.50%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 12.21% vs -15.88% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 178.36% vs -245.77% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
131.37
119.22
10.19%
Operating Profit (PBDIT) excl Other Income
2.67
0.58
360.34%
Interest
3.31
2.86
15.73%
Exceptional Items
0.00
0.00
Consolidate Net Profit
5.20
-2.46
311.38%
Operating Profit Margin (Excl OI)
2.03%
0.49%
1.54%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 10.19% vs -5.26% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 311.38% vs -143.85% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
173.57
170.28
1.93%
Operating Profit (PBDIT) excl Other Income
6.31
8.57
-26.37%
Interest
3.76
2.44
54.10%
Exceptional Items
0.00
0.00
Consolidate Net Profit
5.68
11.45
-50.39%
Operating Profit Margin (Excl OI)
3.64%
5.03%
-1.39%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 1.93% vs -13.45% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is -50.39% vs -75.75% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Ambalal Sarabhai Enterprises Ltd stock-summary
stock-summary
Ambalal Sarabhai Enterprises Ltd
Micro Cap
Pharmaceuticals & Drugs
Ambalal Sarabhai Enterprises Ltd., incorporated on June 5, 1978, houses a range of companies across multi-dimensional businesses. Each subsidiary is a distinct entity contributing its unique expertise and capabilities. It is one of the oldest pharmaceutical health care companies in India, and today through its group companies it manufactures and markets pharmaceutical, molecular diagnostics, and electronics products in India and internationally.
Company Coordinates stock-summary
Company Details
Shanti Sadan, Mirzapur Road Ahmedabad Gujarat : 380001
stock-summary
Tel: 91-79-25507671/25507073
stock-summary
http://www.ase.life
stock-summary
ketanadhvaryu@sarabhai.co.in
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."